SCHEMBL7604439

SCHEMBL7604439

CC(C(=O)O)c1cccc2[nH]cc(P(=O)(O)Cc3ccccc3)c12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
KDM4E B2RXH2 3/20 0.36
POLB P06746 2/20 0.36
RECQL P46063 2/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
APAF1 O14727 1/20 0.36
HTR2A P28223 1/20 0.36
KMT2A Q03164 6/20 0.35
MEN1 O00255 5/20 0.35
ALDH1A1 P00352 3/20 0.35
TDP1 Q9NUW8 2/20 0.35
GAA P10253 1/20 0.35
THRB P10828 1/20 0.35
DNMT1 P26358 1/20 0.35
CASP6 P55212 1/20 0.35
MCL1 Q07820 1/20 0.35
SLC6A2 P23975 1/20 0.34
FNTA P49354 1/20 0.34
FNTB P49356 1/20 0.34
GRIN2D O15399 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7606674 0.86 KMT2A (0.36) MAPTKDM4EPOLBRECQLL3MBTL1
SCHEMBL7609653 0.73 PTGS2 (0.36) KMT2AMEN1ALDH1A1CYP1A2
SCHEMBL8460361 0.73 MEN1 (0.38) KMT2AMEN1CYP1A2
SCHEMBL7609843 0.71 ALDH1A1 (0.38) KDM4EL3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL6618364 0.69 HTR2A (0.53) MAPTKDM4EPOLBRECQLL3MBTL1
SCHEMBL7604589 0.68 ALOX15 (0.37) MAPTKDM4EKMT2AMEN1ALDH1A1
SCHEMBL7607365 0.68 KDM4E (0.37) MAPTKDM4EPOLBRECQLL3MBTL1
SCHEMBL7604596 0.68 CXCL8 (0.36) KDM4EPOLBKMT2AMEN1GRIN2D
SCHEMBL7603822 0.68 GRIN2D (0.35) KDM4EPOLBKMT2AMEN1ALDH1A1
SCHEMBL7609311 0.67 KMT2A (0.36) MAPTPOLBKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2002515040-A 2002-05-21 JP claimed
JP-2002514160-A 2002-05-14 JP claimed
EP-0954295-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-11-10 EP claimed
EP-0936914-A4 1999-08-25 EP claimed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP claimed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed
WO-1997048409-A1 METHODS OF CANCER TREATMENT USING NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO claimed
EP-0936914-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1999-08-25 EP disclosed
EP-0936914-A4 1999-08-25 EP disclosed
WO-1997048400-A1 HYDROXY-PHOSPHINYL DERIVATIVES USEFUL AS NAALADASE INHIBITORS GUILFORD PHARMACEUTICALS INC. (US) 1997-12-24 WO disclosed